Venus Concept Inc.
DelistedCIK 1409269fmd_0TRBFDQFAKCDVT1QKX4YK4VMB2Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2015 to Sep 30, 2025, 40 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 17 | 16 | 21 | 103 | 110 | 78 | 106 | 99 | 76 | 65 |
| Cost of revenue | 13 | 10 | 12 | 23 | 34 | 27 | 32 | 34 | 24 | 21 |
| Gross profit | 5 | 5 | 9 | 79 | 77 | 51 | 74 | 66 | 52 | 44 |
| Research and development | 7 | 7 | 7 | 7 | 8 | 8 | 10 | 11 | 8 | 7 |
| Selling, general and administrative | 18 | 17 | 19 | 65 | 99 | 84 | 82 | 90 | 72 | 65 |
| Total operating expenses | 25 | 24 | 26 | 83 | 107 | 119 | 89 | 101 | 80 | 71 |
| Operating income | (21) | (19) | (17) | (3) | (30) | (68) | (15) | (35) | (28) | (27) |
| Interest expense | – | – | – | 5 | 7 | 8 | 4 | 4 | 7 | 6 |
| Other non-operating income (expense) | (2) | (3) | (1) | (3) | – | – | – | – | – | – |
| Income before taxes | (23) | (22) | (18) | (12) | (40) | (82) | (23) | (44) | (37) | (48) |
| Income tax expense | – | – | 0 | 2 | 2 | 1 | (1) | (1) | (0) | (1) |
| Net income from continuing operations | – | – | (18) | (14) | (42) | (83) | (22) | (44) | (37) | (47) |
| Net income | (23) | (22) | (18) | (15) | (41) | (82) | (23) | (44) | (37) | (47) |
| Net income to common shareholders | – | – | – | (15) | (41) | (85) | (23) | (44) | (37) | (47) |